Comments

CNS Pharma Stock Price, Quotes and Forecasts

Q: What sector and industry does CNS Pharma (CNSP) operate in?

CNS Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

CNSPNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$1.07

At close: May 30 EDT

$1.01

-0.06-5.61%

Pre-Market: 5:05 AM EDT

CNS Pharma (CNSP) Forecast

News Earnings CNS Pharma (CNSP) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

CNS Pharma Stock Price, Quotes and Forecasts | NASDAQ:CNSP | Benzinga

Explore CNS Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CNSP.

Open	-
Close	-
Volume / Avg.	3.55K / 1.72M
Day Range	- - -
52 Wk Range	0.77 - 637.25
Market Cap	$5.52M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	13.4%
Days to Cover	1

Recent News

Nasdaq Gains 50 Points, US New Home Sales Rise In February

Avi Kapoor

CNS Pharma's Cancer Drug Misses Survival Goal But May Offer Fewer Side Effects

CNS Pharmaceuticals' Berubicin trial results show a favorable safety profile with no cardiotoxicity and comparable efficacy to Lomustine in recurrent GBM.

Vandana Singh

US Stocks Mixed; Core & Main Posts Downbeat Earnings

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	3.55K / 1.72M
Day Range	- - -
52 Wk Range	0.77 - 637.25
Market Cap	$5.52M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	13.4%
Days to Cover	1

About Cns Pharmaceuticals Inc

Sector

Health Care

Industry

Pharmaceuticals

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of ant...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy CNS Pharma (CNSP) stock?

You can purchase shares of CNS Pharma (NASDAQ:CNSP) through any online brokerage.

View our list of the best stock brokerages

Who are CNS Pharma (CNSP) competitors?

Other companies in CNS Pharma’s space includes: 60 Degrees (NASDAQ:SXTP), Addex Therapeutics (NASDAQ:ADXN), Kiora Pharmaceuticals (NASDAQ:KPRX), Jaguar Health (NASDAQ:JAGX) and Sonoma Pharmaceuticals (NASDAQ:SNOA).

What is the forecast, or price target, for CNS Pharma (CNSP) stock?

There is no analysis for CNS Pharma to provide a consensus price target.

What is the current price for CNS Pharma (CNSP)?

The stock price for CNS Pharma (NASDAQ: CNSP) is $1.01 last updated May 30, 2025 at 5:05 AM EDT.

Does CNS Pharma (CNSP) pay a dividend?

There are no upcoming dividends for CNS Pharma.

When is CNS Pharma (NASDAQ:CNSP) reporting earnings?

CNS Pharma’s Q2 earnings are confirmed for Wednesday, August 13, 2025.

Is CNS Pharma (CNSP) going to split?

There is no upcoming split for CNS Pharma.

What sector and industry does CNS Pharma (CNSP) operate in?

CNS Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.